Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Simvastatin and side effects.

R S Scott1, C J Lintott, M J Wilson

  • 1Princess Margaret Hospital, Christchurch.

The New Zealand Medical Journal
|November 27, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intraoperative Cell Salvage for Revision Hip Arthroplasty: A 24-Year Study of Transfusion Requirements.

JB & JS open access·2025
Same author

First Measurement of the Nuclear-Recoil Ionization Yield in Silicon at 100 eV.

Physical review letters·2023
Same author

COVID-19 Pandemic Associations on Mental and Physical Health in African Americans Participating in a Behavioral Intervention.

Journal of racial and ethnic health disparities·2022
Same author

Constraints on Lightly Ionizing Particles from CDMSlite.

Physical review letters·2021
Same author

Light Dark Matter Search with a High-Resolution Athermal Phonon Detector Operated above Ground.

Physical review letters·2021
Same author

Development and preliminary evaluation of the Neurofibromatosis Type 1 Adult Quality of Life (NF1-AdQoL) questionnaire.

Clinical and experimental dermatology·2021

Simvastatin, a cholesterol-lowering drug, showed a higher side effect rate in routine use than in clinical trials. Most patients tolerated it well, but muscle aches and GI issues were most common.

Area of Science:

  • Pharmacology
  • Clinical Medicine
  • Cardiovascular Disease Management

Background:

  • Simvastatin is a new cholesterol-lowering medication.
  • High cholesterol (hypercholesterolemia) is a significant risk factor for cardiovascular disease.
  • Effective management of hypercholesterolemia is crucial for public health.

Purpose of the Study:

  • To evaluate the symptomatic and biochemical side effect profile of simvastatin during routine clinical use.
  • To compare side effect rates in a real-world setting versus clinical trial data.
  • To assess patient tolerance and adverse events associated with simvastatin therapy.

Main Methods:

  • A prospective study involving 110 patients initiated on simvastatin at a lipid disorders clinic.
  • Patients completed a side effect questionnaire and underwent biochemical evaluation at six months of therapy.

Related Experiment Videos

  • Data collection occurred during the first ten months of simvastatin's prescription availability.

    • Main Results:

    • 76.4% of patients reported no side effects; 8% felt better.
    • 19.1% experienced side effects but continued therapy; 4.5% discontinued due to side effects.
    • Most common side effects were muscle ache (13.6%) and gastrointestinal symptoms (4.5%). No biochemical abnormalities were detected.

    Conclusions:

    • The rate of reported side effects in routine use exceeded clinical trial findings.
    • Simvastatin is generally effective and well-tolerated, likely gaining wide acceptance for high-risk patients.
    • Physician awareness of common simvastatin side effects and their frequency is essential for optimal patient management.